Related references
Note: Only part of the references are listed.Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease Report of the Quality Standards Subcommittee of the American Academy of Neurology
T. A. Zesiewicz et al.
NEUROLOGY (2010)
Rotigotine transdermal delivery for the treatment of Parkinson's disease
Olivier Rascol et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Validation of the Parkinson's disease sleep scale in Japanese patients: A comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and Polysomnography
Yusuke Uemura et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Intrajejunal Levodopa Infusion in Parkinson's Disease: A Pilot Multicenter Study of Effects on Nonmotor Symptoms and Quality of Life
Holger Honig et al.
MOVEMENT DISORDERS (2009)
International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease
P. Martinez-Martin et al.
NEUROLOGY (2009)
Psychometric properties of the Parkinson's Disease Sleep Scale - Brazilian version
Regina Margis et al.
PARKINSONISM & RELATED DISORDERS (2009)
Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease: A Prospective Multicenter Study
Irena Rektorova et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Continuous jejunal levodopa infusion in patients with advanced Parkinson disease:: Practical aspects and outcome of motor and non-motor complications
Karla Eggert et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Rotigotine transdermal system for the treatment of Parkinson's disease
David Q. Pham et al.
CLINICAL THERAPEUTICS (2008)
Non-motor symptoms in Parkinson's disease
W. Poewe
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale
Gang Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease
R. Pahwa et al.
NEUROLOGY (2007)
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study
A. Romigi et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Reliability and validity of the Beck Depression Inventory in patients with Parkinson's disease
M Visser et al.
MOVEMENT DISORDERS (2006)
Continuous subcutaneous apomorphine therapy improves Dyskinesias in Parkinson's disease: A prospective study using single-dose challenges
R Katzenschlager et al.
MOVEMENT DISORDERS (2005)
Parkinson's disease Sleep Scale:: Validation study of a Spanish version
P Martínez-Martín et al.
MOVEMENT DISORDERS (2004)
The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease
B Högl et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease - A meta-analysis
M Etminan et al.
DRUG SAFETY (2003)
The Parkinson's disease sleep scale:: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease
KR Chaudhuri et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Share Paper
